Longer Time to Reach Excellent Response to Treatment in Familial Versus Sporadic Non-medullary Thyroid Cancer (NMTC): A Matched Case-Control Study.

Susan ShafieiMehrdokht SadrolodabaeiAtena AghaeeNarjess AyatiSamira Zare NamdarDonya HematiSeyed Rasoul Zakavi

Published in: International journal of endocrinology and metabolism (2021)

Our study showed that if patients with familial NMTCs were treated in the same way as non-familial patients, the time to excellent response would be significantly longer, even when they have only one other involved relative.

Keyphrases

early onset
newly diagnosed
ejection fraction
late onset
prognostic factors
patient reported outcomes
patient reported